Advertisement

Document › Details
Genomics plc. (1/16/18). "Press Release: Jeff Barrett Joins Genomics plc as CSO". Oxford.
![]() |
Organisation | Genomics plc |
Organisation 2 | Genomics plc, Cambridge UK Office | |
Today | Immuneed (Group) | |
Group | Genomics plc | |
![]() |
Product | genomics |
Product 2 | genomic software tools | |
![]() |
Person | Barrett, Jeff (Genomics plc 201803– CSO before Wellcome Sanger Institute) |
We are delighted to announce that Dr Jeff Barrett will be joining Genomics plc as Chief Scientific Officer and Director.
Jeff is an international leader in human and statistical genetics. He is the Founding Director of Open Targets, an open innovation partnership focussed on improving early stage drug development, and a Senior Group Leader at the Wellcome Sanger Institute. Jeff has had a major impact in advancing our understanding of the genetics of several important human diseases, and in pioneering innovative research approaches. He has extensive experience in analysing genomic data to understand human biology, and has played a leading role in a number of major international studies. Jeff obtained his undergraduate degree at MIT and his doctorate at the University of Oxford.
Peter Donnelly, CEO of Genomics plc, commented: “We are thrilled that Jeff is joining the team. I have been fortunate to have worked with Jeff over many years, and watched at first hand his impressive leadership in our field. He is an outstanding scientist, with a deep understanding of the potential for genetics to impact on drug development. His involvement will make a big difference to our company.”
Jeff commented: “I am delighted to be joining Genomics as CSO. We are at a point where genetics is poised to transform our understanding of human biology and, in the process, ensure that drugs are developed much more efficiently. Genomics plc is extremely well placed to play a leading role in that transformation, given the scientific capabilities of the team, the scale and quality of the data assembled, and the powerful algorithms developed. I am excited about helping the team succeed in its mission”.
Jeff joins the company in March 2018.
Record changed: 2023-06-05 |
Advertisement

More documents for Genomics plc
- [1] Genomics plc. (10/5/20). "Press Release: Daniel Vogel Joins Genomics plc as Chief Financial Officer". Oxford....
- [2] Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford....
- [3] Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford....
- [4] Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford....
- [5] Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford....
- [6] Genomics plc. (8/28/18). "Press Release: Opening of Cambridge Office". Cambridge....
- [7] Genomics plc. (10/16/17). "Press Release: Genomics plc Teams Up with Biogen to Discover New Drug Targets for Multiple Sclerosis". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top